|ZYGO Facility Receives Certification for Medical Product Manufacturing|
|MIDDLEFIELD, CT, Mar 15, 2007 (MARKET WIRE via COMTEX News Network) -- Zygo Corporation (NASDAQ: ZIGO), a worldwide supplier of optical
metrology instruments and high precision optical systems, today
announced that its Tucson, Arizona, operation has received ISO
13485:2003 certification for medical product manufacturing. The
addition of this certification reinforces ZYGO's demonstrated ongoing
commitment to improving our business processes to consistently meet
and exceed our customers' expectations. The facility's quality system
is also certified to ISO 9001:2000.
ISO 13485:2003: Medical devices - Quality Management Systems (QMS) -- The ISO 13485 registration requires a variety of stringent controls that include compliance with U.S. Food and Drug Administration (FDA), product traceability, increased detail and control of technical data, customer complaint documentation and follow-up procedures, environment monitoring, and risk identification and analysis.
John Stack, President of ZYGO's Optics business segment, stated, "This certification provides a critical building block for our continued growth in the high precision medical device market and is yet another example of the ongoing dedication to quality by our world-class Tucson assembly operation. The Tucson operation is currently producing a number of high precision medical laser delivery and imaging-based systems in conjunction with its sister design and prototyping facility located in Costa Mesa, California."
Zygo Corporation is a worldwide supplier of optical metrology instruments, precision optics, and electro-optical design and manufacturing services, serving customers in the semiconductor capital equipment and industrial markets.
All statements other than statements of historical fact included in this news release regarding our financial position, business strategy, plans, anticipated growth rates, and objectives of management of the Company for future operations are forward-looking statements. Forward-looking statements are intended to provide management's current expectations or plans for the future operating and financial performance of the Company based upon information currently available and assumptions currently believed to be valid. Forward-looking statements can be identified by the use of words such as "anticipate," "believe," "estimate," "expect," "intend," "plans," "strategy," "project," and other words of similar meaning in connection with a discussion of future operating or financial performance. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors. Among the important factors that could cause actual events to differ materially from those in the forward-looking statements are fluctuations in capital spending of our customers, fluctuations in net sales to our major customer, manufacturing and supplier risks, dependence on and timing of new product development, rapid technological and market change, risks in international operations, dependence on proprietary technology and key personnel, length of the sales cycle, environmental regulations, and fluctuations in our stock price. Further information on potential factors that could affect Zygo Corporation's business is described in our reports on file with the Securities and Exchange Commission, including our Form 10-K for the fiscal year ended June 30, 2006.
Walter Shephard Vice President Finance, Chief Financial Officer, and Treasurer Voice: 860-704-3955 Contact via http://www.marketwire.com/mw/emailprcntct?id=C9E4D4E92772739F
SOURCE: Zygo Corporation
|ASPE Annual Meeting||11/06|
|MRS Fall Meeting||11/27|
|(Click for a complete list)|